five

COVID 19 SARS COV2 targets and small molecule data including insilico analysis

收藏
NIAID Data Ecosystem2026-03-11 收录
下载链接:
https://zenodo.org/record/3872005
下载链接
链接失效反馈
官方服务:
资源简介:
Welcome to the repository for the COVID-19 research data. Corresponding Author: Girinath G. Pillai and few experts Co-authors: Team of experts, scholars and students To join dedicated Slack Discussion : https://join.slack.com/t/nyroindia/shared_invite/zt-ejes216c-QZzEK_G5tNKIjewbVj2IPA We commit to conduct research analysis and all the findings and data will be open and anyone can use or help us improve the data. The parameters for checkpoints are: A) Pharmacophore Modelling - i) generate pharmacophore reference maps from XRay crystal geometry, ii) Generate all possible conformers of the dataset molecules for screening. B) Virtual Screening - i) highest docking score within the dataset, ii) lowest clashes (interligand or intraligand), iii) interactions with key amino acid residues based on literature reports, PROSITE server and pocket finding algorithm like DoGSite or CASTp iv) optimal LE values and v) satisfactory interactions between small molecules and amino acids. C) Selection - i) binding affinity range predictions, lowest among the dataset, ii) free binding energy calculation considering desolvation terms, lowest among the dataset and iii) torsion analysis - coverage of bonds in CSD database. D) Optimization - i) pharmacokinetic properties to be generated from selected hits and an optimal balance of properties to be considered for candidate selection criteria. E) For novel lead molecules - i) chemical space exploration on building blocks could be carried out, ii) on-demand synthesis and procurement. If you prefer you could always cite https://github.com/giribio/COVID19 Feel free to create any issues in Github or feel free to contact me via Slack for any queries. Thanks and let us fight against COVID-19 in all possible ways.
创建时间:
2020-06-02
5,000+
优质数据集
54 个
任务类型
进入经典数据集
二维码
社区交流群

面向社区/商业的数据集话题

二维码
科研交流群

面向高校/科研机构的开源数据集话题

数据驱动未来

携手共赢发展

商业合作